Cadilap Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Lapatinib (250mg)
Overview Cadilap Tablet
Cadilas medication is indicated for breast cancer management. Its mechanism involves inhibiting or retarding cancerous cell proliferation. It's administered either independently or alongside other therapies to manage advanced breast cancer. Cadilas should be ingested on an empty stomach, or one hour prior to, or two hours after, a meal. Dosage and treatment length are individualized based on disease severity and patient response. Strict adherence to the prescribed regimen is crucial to minimize adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinuation should only occur under physician guidance. Frequently reported side effects encompass nausea, headache, back pain, and respiratory distress. Severe diarrhea warrants increased fluid intake or medical consultation. Regular blood pressure monitoring is often recommended. Report severe headache, confusion, visual disturbances, persistent nausea, or vomiting to your physician immediately. Liver function assessment may be performed pre-, during, and post-treatment. Pre-treatment disclosure of liver or kidney conditions is essential. Interactions with other medications are possible; comprehensive disclosure of all medications to your healthcare provider is crucial. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is vital throughout the treatment period.
Primary Ingredients of Cadilap Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cadilap Tablet
Malignant breast tumor
Major Benefits of Cadilap Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cadilap Tablet on an empty stomach.
Common Side effects of Cadilap Tablet:
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use Cadilap Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cadilap Tablet on an empty stomach.
How Cadilap Tablet works:
Cadilap tablets function as an anti-neoplastic agent, targeting HER2 and EGFR receptors—proteins that drive excessive cell replication. By binding to these receptors, the drug blocks their activity, thereby suppressing the uncontrolled growth of cancer cells and the associated signaling cascades.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cadilap Tablet hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Cadilap tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Using Cadilap Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Cadilap Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Cadilap Tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. Data on Cadilap Tablet's use in such patients is limited. Dosage changes are not advised for those with mild to moderate kidney disease.
LiverCAUTION
Patients with liver impairment should use Cadilap Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data regarding its use in patients exhibiting severe hepatic dysfunction is scarce.
What if you forget to take Cadilap Tablet :
Omit a Cadilap Tablet dose? Seek your physician's advice.
Facts to Know About Cadilap Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline Amine Derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently